Le Lézard
Classified in: Health
Subject: FDA

Q'Apel Medical Announces FDA Clearance for Walrus Balloon Guide Catheter


FREMONT, Calif., July 17, 2019 /PRNewswire/ -- Q'Apel Medical announced today that it received U.S. Food and Drug Administration clearance for its novel walrus Balloon Guide Catheter (BGC). 

Logo

In the neurovascular space where speed, reliability and performance are so critical to patient outcomes, physicians and patients demand that innovative technologies are best-in-class. The walrus BGC, with its 087 ID, marks a big step forward in balloon guide catheter technology and for stroke patients worldwide. 

"Catheter compatibility in the neurovascular space is critical to the treatment of stroke patients. Until now, widespread adoption of BGCs has been limited due to technical constraints. The walrus BGC was specifically designed to address these technical shortcomings with an 087 ID in a highly trackable catheter platform," said Raymond Turner MD, professor of neurosurgery at Prisma Health. "I expect its introduction will be welcomed by neurovascular physicians everywhere." 

The walrus BGC represents the second FDA-cleared technology from Q'Apel in the past 12 months, joining the wahoo Access Catheter with Selectflex technology in Q'Apel's expanding product portfolio. Q'Apel has several more innovative products slated to come to market over the course of the next year. 

About Q'Apel Medical LLC

Q'Apel Medical LLC is a medical device company founded with the sole purpose of developing best-in-class technology for neurovascular interventions. Learn more about Q'Apel at www.option3llc.com/portfolio.

For more information about Q'Apel and the walrus BGC, please email info@option3llc.com.

Related Images

qapel-medical.jpg

SOURCE Q'Apel Medical


These press releases may also interest you

at 03:00
Trust must be earned. It's a slow, gradual, and fragile process, which is often the reason why many people are unwilling to place their faith in others. Yet the motives behind a deep sense of distrust can be complex. Some people use it as a means of...

24 jan 2020
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into CV Sciences, Inc. .   In 2016, the...

24 jan 2020
Agropur Cooperative is recalling certain milk products from the marketplace due to the presence of sanitizer. Consumers should not consume the recalled products described below. The following products have been sold in Ontario and Quebec. Recalled...

24 jan 2020
(AANA) ? In honor of National CRNA Week (Jan. 19-25, 2020), Reps. Jan Schakowsky (D-IL), Lucille Roybal-Allard (D-CA), and Sam Graves (R-MO) today introduced a bipartisan resolution on the House floor, "Recognizing the roles and the contributions of...

24 jan 2020
Worldwide Business with kathy ireland® has announced an exclusive interview with Rapid Release Technology President Dr. Stanley Stanbridge and Vice President of Sales and Marketing Jeff Maier to discuss their innovative technology, High-Speed...

24 jan 2020
Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics ("Nektar" or the "Company") .  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The investigation...



News published on 17 july 2019 at 00:39 and distributed by: